MedPath
HSA Approval

SW BENA-EXPECTORANT

SIN02911P

SW BENA-EXPECTORANT

SW BENA-EXPECTORANT

May 22, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05FB01

cough suppressants and mucolytics

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

SODIUM CITRATE

46 mg/5 ml

Sodium citrate

AMMONIUM CHLORIDE

102 mg/5 ml

Ammonium chloride

DIPHENHYDRAMINE HCl

10 mg/5 ml

Diphenhydramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SW BENA-EXPECTORANT - HSA Approval | MedPath